Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

MLCARE Machine Learning Computational Advancements for peRsonalized mEdicine

Coordinator
Universidad Carlos Iii De Madrid, Spain
Runs
1 January 2026 to 31 December 2029
Status
Running
EU funding
€3.9m
Total cost
—
Partners
24 organisations in 10 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101226456

What the project is doing

In the project's own words, from its summary on CORDIS.

Personalized medicine represents a paradigm shift in healthcare, transitioning from generalized treatment strategies to highly personalized care. This transformation is driven by rapid advancements in digital technologies, which generate massive volumes of data from diverse sources, including genomic sequences, high-resolution imaging, wearable devices, and electronic health records (EHRs). However, despite an annual estimate of 50 petabytes of data generated per hospital, only a fraction is utilized effectively.

Harnessing this untapped potential offers a transformative opportunity to uncover novel disease mechanisms and deliver more precise and effective therapeutic interventions. The MLCARE project seeks to revolutionize personalized medicine by developing cutting-edge AI solutions that integrate genomic, clinical, and environmental data into holistic, multimodal patient representations. Through innovative approaches such as Foundation Models and advanced generative AI methods, MLCARE will address critical challenges in processing complex, high-dimensional, and multimodal datasets.

Emphasis will be placed on ensuring the trustworthiness, explainability, and security of AI applications to support real-world clinical decision-making. A core mission of MLCARE is to train a new generation of interdisciplinary researchers with expertise spanning AI, computational biology, and healthcare. The program will equip doctoral candidates with the technical, analytical, and ethical skills needed to lead the future of patient-centered, AI-driven medicine.

By combining state-of-the-art research with a comprehensive training program, MLCARE aims to set new standards in personalized healthcare, ensuring equitable, data-driven solutions that improve outcomes across diverse populations. This project is poised to position Europe at the forefront of global innovation in precision medicine, delivering a timely and impactful response to evolving healthcare challenges.

Who is involved

OrganisationCityCountryRole
Universidad Carlos Iii De MadridGetafe (Madrid)SpainCoordinator
Universite De LiegeLiegeBelgiumParticipant
Eidgenoessische Technische Hochschule ZuerichZuerichSwitzerlandAssociatedpartner
Hmnc Holding GmbHMunchenGermanyParticipant
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyParticipant
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eVMunchenGermanyParticipant
Siemens Healthineers AGForchheimGermanyAssociatedpartner
Kobenhavns UniversitetKobenhavnDenmarkParticipant
Novo Nordisk A/sBagsvaerdDenmarkAssociatedpartner
Tartu UlikoolTartuEstoniaParticipant
Astrazeneca Farmaceutica Spain, S.aMadridSpainAssociatedpartner
Evidence-Based Behavior, SLLeganesSpainAssociatedpartner
Fundacio Barcelonabeta Brain Research CenterBarcelonaSpainParticipant
Fundacion Para La Investigacion Biomedica Del Hospital Gregorio MaranonMadridSpainAssociatedpartner
Fundacion Publica Andaluza Progreso Y Salud M.p.SevillaSpainParticipant
Universidad De SevillaSevillaSpainAssociatedpartner
Universidad Pompeu FabraBarcelonaSpainAssociatedpartner
Institut PasteurParisFranceAssociatedpartner
Universite Paris CiteParisFranceParticipant
Universiteit MaastrichtMaastrichtNetherlandsAssociatedpartner
Pixelgen Technologies ABStockholmSwedenAssociatedpartner
Astrazeneca UK LimitedCambridgeUnited KingdomParticipant
Pharmatics LimitedEdinburghUnited KingdomParticipant
The Chancellor, Masters and Scholars of the University of OxfordOxfordUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI